Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Bio-Rad logo
    21 October 2025

    Bio-Rad’s iQ-Check Enterobacteriaceae Kit validated for detection of Enterobacteriaceae in infant formula and cereals

    Certified by MicroVal for Detection of Enterobacteriaceae Including Salmonella, Cronobacter, and E.coli as Indicator of Process Effectiveness to Eliminate Contaminants in Infant Formula and Related Ingredients. ...

    Enamine
    21 October 2025

    Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

    Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate2,000 new compounds generated for the programme are now available from Enamine’s catalogueKyiv, Ukraine, 21 October, 202...

    https://mosaic-tx.com/
    20 October 2025

    Mosaic Therapeutics appoints Thomas Fuchs as CEO

    Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadershipAppointment strengthens executive leadership team and supports transition into clinical developmentCambridge, UK, 20 October ...

    giles AI
    20 October 2025

    giles introduces AI agent to accelerate healthcare and life science research

    AI tool connects researchers to verified medical and life sciences global databases, enabling accurate extraction and summarisation of academic papers, journals, and articlesgiles will be showcased at ISPOR Europe 2025, Glasgow, 9-12th November, booth 314London, UK, 20 October 2025: gil...

    BLE Antenna Design for Implantable Continuous Glucose Monitors
    21 October 2025

    TTP improves Bluetooth connectivity for implantable continuous glucose monitors

    TTP’s Biosensing team has tackled one of the biggest challenges in implantable continuous glucose monitors: achieving reliable Bluetooth® Low Energy (BLE) connectivity within extreme size and power constraints. By taking a system-level approach that integrates RF design, antenna miniatu...

    Prof. Kevin Chalut, CSO and Co-Founder, and Dr. Léa Wenger, CEO and Co-Founder, Cyclana Bio	The Cyclana Bio team
    20 October 2025

    Cyclana Bio raises £5M to advance drug discovery for Endometriosis

    Co-led by NfX and Eka VC, investors include Cocoa VC, Wilbe, and Angel investorsInvestment will support development of whole tissue-based platform for identification of druggable targets and scaling of observational clinical trialCambridge, UK, 20th October 2025 – Cyclana Bio, a bi...

    population health
    21 October 2025

    Population health in respiratory care: From data to actionable insights

    In an era where healthcare systems face mounting pressures from chronic disease burdens, population health has emerged as a strategic framework to improve outcomes across communities rather than focusing solely on individual patients. Respiratory diseases, in particular chronic obstruct...

    TTP Certified ISO 13485 Manufacturing for Medical Devices and IVDs
    16 October 2025

    TTP Plc extends ISO 13485 certification to contract manufacture of medical devices and IVDs

    TTP plc has expanded its ISO 13485 certification to include the contract manufacture of medical devices and in vitro diagnostics, covering implantable and active implantable devices. This extension builds on TTP’s 15-year track record in ISO-certified medical device development and rein...

    sperm under microscope
    9 October 2025

    Hidden evolution in sperm raises disease risk for children as men age

    Harmful genetic changes in sperm become substantially more common as men age because some are actively favoured during sperm production, new research has revealed.  ...

    Image credit: David Levene / Wellcome Sanger Institute
    9 October 2025

    Improved genetic tool reveals hidden mutations that can drive cancer

    Researchers have refined a powerful DNA sequencing tool that can uncover hidden mutations that occur naturally in our bodies as we age. In the largest study to date, they have used the tool to provide insights into the earliest steps of cancer development and the role of mutations in he...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 42
    • Page 43
    • Current page 44
    • Page 45
    • Page 46
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS